Aurinia Pharmaceuticals Inc (AUPH)
EBITDA Growth
93.94%
Quarterly · Period ending:
AUPH EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported93.94%period ending
Latest reported93.94%period ending
AUPH Quarterly EBITDA YoY % (-471.77% → 93.94%)
Year-over-year change
High-resolution chart · PNG
AUPH ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -418.1639% | |
| -156,522.7453% | |
| -311.5781% | |
| -471.7717% |